Are they also working on a redesigned Trobalt? That is does it also work on the ion channels to calm our hyper active neurons down? Then probably the trial you are referring to ishttp://investor.xenon-pharma.com/ne...euticals-reports-first-quarter-2020-financial
Xenon's press release. No mention of tinnitus. They say they are exploring uses for other neurological disorders. XEN1101, the most likely to be relevant to us, is expected to complete an ongoing phase 2b trial in the first half of 2021.
https://clinicaltrials.gov/ct2/show/NCT03796962
Completion is then probably delayed because of COVID-19 from July 2020 to beginning 2021.